Non-pathogenic bacteria block inflammatory response pathway in intestinal tract

A team of Emory University pathologists has discovered that non-pathogenic bacteria within the gastrointestinal tract may be responsible for blocking an immune pathway that otherwise could cause an unhealthy inflammatory response to the millions of bacteria normally present in the intestine. A breakdown in this mechanism for bacterial tolerance could play a fundamental role in the pathogenesis of inflammatory bowel disease (Crohn's disease and ulcerative colitis) and other infectious intestinal diseases. The research was reported in the September 1 issue of the journal Science.

The gastrointestinal tract of humans and other vertebrates is home to a delicate bacterial balancing act in which a diverse ecosystem of non-pathogenic bacteria co-exist among potential pathogens, all under the watchful guard of protective immune cells. Although the intestinal non-pathogenic bacteria, or normal flora, are known to play a biological role in enabling the breakdown of certain vitamins and other substances, scientists have generally believed these bacteria to be otherwise inert residents of the GI tract. The usually harmonious co-existence between intestinal organisms and immune cells dates back through millions of years of evolution, from the time of the earliest known vertebrates.

The Emory team of pathologists, including Andrew Neish, M.D., James Madara, M.D. and Andrew Gewirtz, Ph.D., and their colleagues, discovered that non-pathogenic bacteria in the G.I. tract are not merely the innocent intestinal wallflowers they were presumed to be, but that they actually deliver a signal that blocks an important immune-system pathway called NF-KB -- a transcription factor involved in activating genes in the immune system.

"It's fascinating that the epithelium (lining of the intestine) can tolerate the presence of this density of bacteria while also being quite permeable to nutrients and fluids," says Dr. Neish. "Almost all other tissue types in the body are exq

Contact: Holly Korschun
Emory University Health Sciences Center

Page: 1 2

Related medicine news :

1. Oral bacteria may predict pregnancy outcomes
2. Study finds direct association between cardiovascular disease and periodontal bacteria
3. Substance protects resilient staph bacteria
4. Discovery of key proteins shape could lead to improved bacterial pneumonia vaccine
5. Bacteria-killing vs. bacteria-inhibiting drugs in treating infections
6. Patients undergoing weight loss surgery have high rates of H pylori bacteria
7. Outbreak of skin infections sheds light on risk factors for bacterial resistance
8. Popular chewing gum eliminates bacteria that cause bad breath
9. Antibiotic resistant bacteria frequently transmitted between intensive care patients
10. New weapon to combat resistant bacteria
11. High level of antibiotic resistance in bacteria that cause food poisoning

Post Your Comments:
(Date:5/5/2015)... Igantia , an emerging biotechnology and ... initiative to examine key biological milestones during a woman’s ... Scientists at Igantia believe that better understanding of the ... her menstrual cycle to her transition into menopause, they ... extend the lifespan. , By recently announcing the ...
(Date:5/5/2015)... 2015 NovaSom, Inc., announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... This segment will focus on NovaSom, a leader in ... about their AccuSom® home sleep test, which is the ... patient support and next-day test results and interpretation. ...
(Date:5/5/2015)... May 05, 2015 HealthSlide, ... innovative interoperability solutions for hospitals nationwide, has announced ... calculator. Hospital CIOs and CTOs can access the ... calculator shows both initial and ongoing savings of ... , “Our nation’s hospitals pay an average of ...
(Date:5/5/2015)... May 05, 2015 Care ... guidebook called “Medicare Breakeven Challenges? A Model ... includes:, ,     Formulas for two ... measuring but should be ,     A ... “white space” and ensures sustained efficient operations ...
(Date:5/5/2015)... MO (PRWEB) May 05, 2015 After ... bar flavors in 2014, Walgreens introduces the Cookies & ... focusing on innovation, Extend Nutrition has continually raised the ... a great taste, combined with an unprecedented nutritional profile, ... on this success, Extend Nutrition will launch additional new ...
Breaking Medicine News(10 mins):Health News:Igantia Announces Digital Initiative to Decode Longevity 2Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:HealthSlide Launches ROI Cost Calculator 2Health News:Care Logistics Publishes a New Hospital Guidebook for Achieving Medicare Breakeven 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research and ... addition of the "Will Theranos Turn the Lab ... Theranos has received much praise along with a ... have "gone public" with their potentially disruptive laboratory solution. ... question: Has Theranos scaled microfluidic technology across ...
(Date:5/5/2015)... -- - No one has covered cath ... ABMRG - Primary research covering 700 angioplasty ... among states & regions; hospital chains; govt. & pvt. ... coronary stent market in India , ... (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 ...
(Date:5/5/2015)... 5, 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: ... that specializes in developing safer, more effective cannabis-based ... investor, and Non-Executive Director, Peter Mountford , ... with primary responsibility for the European markets. ... leverage his previous success in the emerging field ...
Breaking Medicine Technology:Will Theranos Turn the Lab Industry Upside Down? 2India Coronary Stent Market to be Tripled by 2021 2India Coronary Stent Market to be Tripled by 2021 3India Coronary Stent Market to be Tripled by 2021 4InMed Engages Peter Mountford as Strategic Advisor 2InMed Engages Peter Mountford as Strategic Advisor 3InMed Engages Peter Mountford as Strategic Advisor 4
Cached News: